393 related articles for article (PubMed ID: 11555762)
1. A study of the effect of nasal steroid sprays in perennial allergic rhinitis patients with rhinitis medicamentosa.
Ferguson BJ; Paramaesvaran S; Rubinstein E
Otolaryngol Head Neck Surg; 2001 Sep; 125(3):253-60. PubMed ID: 11555762
[TBL] [Abstract][Full Text] [Related]
2. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR
Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
[TBL] [Abstract][Full Text] [Related]
3. Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis.
Baroody FM; Brown D; Gavanescu L; DeTineo M; Naclerio RM
J Allergy Clin Immunol; 2011 Apr; 127(4):927-34. PubMed ID: 21377716
[TBL] [Abstract][Full Text] [Related]
4. Clinical and antiinflammatory effects of intranasal budesonide aqueous pump spray in the treatment of perennial allergic rhinitis.
Meltzer EO
Ann Allergy Asthma Immunol; 1998 Aug; 81(2):128-34. PubMed ID: 9723557
[TBL] [Abstract][Full Text] [Related]
5. Effect of budesonide aqueous nasal spray on hypothalamic-pituitary-adrenal axis function in children with allergic rhinitis.
Kim KT; Rabinovitch N; Uryniak T; Simpson B; O'Dowd L; Casty F
Ann Allergy Asthma Immunol; 2004 Jul; 93(1):61-7. PubMed ID: 15281473
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of budesonide aqueous nasal spray and fluticasone propionate nasal spray in the treatment of perennial allergic rhinitis.
Ståhl E; van Rompay W; Wang EC; Thomson DM
Ann Allergy Asthma Immunol; 2000 Apr; 84(4):397-402. PubMed ID: 10795647
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness of oxymetazoline plus intranasal steroid in the treatment of chronic rhinitis: A randomised controlled trial.
Thongngarm T; Assanasen P; Pradubpongsa P; Tantilipikorn P
Asian Pac J Allergy Immunol; 2016 Mar; 34(1):30-7. PubMed ID: 26994623
[TBL] [Abstract][Full Text] [Related]
8. Topical nasal sprays: treatment of allergic rhinitis.
Kobayashi RH; Kiechel F; Kobayashi AL; Mellion MB
Am Fam Physician; 1994 Jul; 50(1):151-7, 161-2. PubMed ID: 7517094
[TBL] [Abstract][Full Text] [Related]
9. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
Graf P
Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860
[TBL] [Abstract][Full Text] [Related]
10. A comparison of nasal clearance after treatment of perennial allergic rhinitis with budesonide and mometasone.
Naclerio RM; Baroody FM; Bidani N; De Tineo M; Penney BC
Otolaryngol Head Neck Surg; 2003 Feb; 128(2):220-7. PubMed ID: 12601318
[TBL] [Abstract][Full Text] [Related]
11. Use of mometasone furoate aqueous nasal spray in the treatment of rhinitis medicamentosa: an experimental study.
Tas A; Yagiz R; Yalcin O; Uzun C; Huseyinova G; Adali MK; Karasalihoglu AR
Otolaryngol Head Neck Surg; 2005 Apr; 132(4):608-12. PubMed ID: 15806055
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
Corren J; Storms W; Bernstein J; Berger W; Nayak A; Sacks H;
Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
[TBL] [Abstract][Full Text] [Related]
13. Adverse effects of benzalkonium chloride on the nasal mucosa: allergic rhinitis and rhinitis medicamentosa.
Graf P
Clin Ther; 1999 Oct; 21(10):1749-55. PubMed ID: 10566570
[TBL] [Abstract][Full Text] [Related]
14. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.
Lieberman P; Kaliner MA; Wheeler WJ
Curr Med Res Opin; 2005 Apr; 21(4):611-8. PubMed ID: 15899111
[TBL] [Abstract][Full Text] [Related]
15. Allergic perennial and non-allergic, vasomotor rhinitis treated with budesonide nasal spray.
Balle VH; Pedersen U; Engby B
Rhinology; 1980 Sep; 18(3):135-42. PubMed ID: 6997974
[TBL] [Abstract][Full Text] [Related]
16. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
Graf P; Hallén H
ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):39-44. PubMed ID: 9104748
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of the effect of oxymetazoline on the duration of rhinitis. results of a placebo-controlled double-blind study in patients with acute rhinitis].
Reinecke S; Tschaikin M
MMW Fortschr Med; 2005 Oct; 147 Suppl 3():113-8. PubMed ID: 16261947
[TBL] [Abstract][Full Text] [Related]
18. A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitis.
Gradman J; Caldwell MF; Wolthers OD
Clin Ther; 2007 Aug; 29(8):1738-47. PubMed ID: 17919555
[TBL] [Abstract][Full Text] [Related]
19. Budesonide - a new nasal steroid.
Pipkorn U; Rundcrantz H; Lindqvist N
Rhinology; 1980 Dec; 18(4):171-5. PubMed ID: 7010515
[TBL] [Abstract][Full Text] [Related]
20. Fluticasone reverses oxymetazoline-induced tachyphylaxis of response and rebound congestion.
Vaidyanathan S; Williamson P; Clearie K; Khan F; Lipworth B
Am J Respir Crit Care Med; 2010 Jul; 182(1):19-24. PubMed ID: 20203244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
